Align Technology (ALGN) Receives Analyst Rating

Align Technology (ALGN) : 10 analysts are covering Align Technology (ALGN) and their average rating on the stock is 1.25, which is read as a Strong Buy. 8 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Align Technology (ALGN) also receives 1 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 2, which recommends a Buy affirms that they expect a large upside in the stock from the current levels. A total of 1 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

Align Technology (ALGN) : The highest short term price target forecast on Align Technology (ALGN) is $115 and the lowest target price is $93. A total of 9 equity analysts are currently covering the company. The average price of all the analysts is $100.33 with a standard deviation of $8.46.


Also, Major Brokerage house, Stifel Nicolaus maintains its ratings on Align Technology (NASDAQ:ALGN). In the latest research report, Stifel Nicolaus raises the target price from $82 per share to $95 per share. According to the latest information available, the shares are now rated Buy by the analysts at the agency. The rating by the firm was issued on July 28, 2016.

Align Technology (NASDAQ:ALGN): After opening at $92.95, the stock dipped to an intraday low of $92.04 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $93.59 and the buying power remained strong till the end. The stock closed at $92.93 for the day, a gain of 0.63% for the day session. The total traded volume was 928,312. The stocks close on the previous trading day was $92.35.

Align Technology, Inc. (Align) is a medical device company. The Company designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services for dentistry, orthodontics, and dental records storage. The Company operates through two segments: Clear Aligner, known as the Invisalign system, and Scanners and Services, known as the iTero intraoral scanner and OrthoCAD services. The Companys Clear Aligner segment provides malocclusion and orthodontic treatment. The Companys Scanners and Services Segment offers iTero intraoral scanner, which utilizes laser and optical scanning to capture the contours of the patients dentition, gingival structures and the bite. It distributes products directly to customers, including orthodontists and general practitioner dentists (GPs), as well as to restorative dentists, including prosthodontists, periodontists and oral surgeons.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.